|
National Advocates for Pregnant Women
45 West 10th Street #3F
New York, New York 10011
http://www.advocatesforpregnantwomen.org
|
FOR IMMEDIATE RELEASE | CONTACT: NAPW |
| May 06, 2002 | 917-921-7421 |
SCHIP Regulation Change May Signal Shift in Experimental Treatment Policy
National Advocates for Pregnant Women Respond to Inconsistencies in Federal
Policy
New York, NY - Today, the National Advocates for Pregnant Women (NAPW)
released commentary on a proposed rule change to the State Child Health
Insurance Program (SCHIP). NAPW's letter addressed Health and Human Secretary
Tommy Thompson's proposal, announced on January 31st, 2002, that would expand
the definition of a child under SCHIP regulations to include fetuses from
conception to birth. The original public announcement drew criticism from
columnists and women's rights organizations nationwide focusing on its
potential effect on a woman's right to have an abortion.
Taking a broader approach, NAPW argues that the proposal is primarily a
political effort to distract attention from a range of pressing public health
issues, and raises the possibility that the proposal marks a major shift in
government policy regarding experimental medical procedures.
The Notice of Proposed Rule Making highlights alleged advances in so called
"fetal surgery" as a justification for the proposal and as an example of the
medical care that would be available as a result of the proposed rule change.
Maternal-Fetal surgery experts, Professors Monica J. Casper and Lynn M.
Morgan, who also submitted commentary, critique this claim in part because
"it . . .casually and blindly overstates the chances that treatments and
surgeries performed on fetuses will result in successful outcomes" (Letter
attached) Lynn M. Paltrow, NAPW's executive director, also notes that the
statement may be read to encourage illegal research on pregnant human
subjects and appears to be in direct conflict with the government's policy
regarding experimental procedures.
"Fetal surgery is still considered experimental," Ms. Paltrow explained. "And
since the federal government has a long-standing policy of denying coverage
for experimental treatments under Medicaid, the implication that the SCHIP
expansion would cover fetal surgery either indicates a radical shift in
policy, or it is deliberately misleading."
NAPW's commentary also argues that the proposed rule change is an exercise in
"political deflection not child-health protection," identifying it as a
political statement intended to provoke controversy over Roe v. Wade and to
distract attention from pressing national issues regarding health care for
Americans, including low income women and children. NAPW's letter joins
scores of others from doctors, academics, activists, public health and
women's organizations, objecting to the proposed change. The deadline for
comment is 5:00 p.m. May 6th, 2002. All comments are available for public
viewing and will be reviewed prior to approval or rejection of the proposed
change in regulations.
NAPW is a nonprofit organization dedicated to protecting the rights of
pregnant and parenting women and their children. NAPW seeks to ensure that
women do not lose their constitutional and human rights as a result of
pregnancy and that addiction and other health and welfare problems that women
face during pregnancy are addressed as health issues, not as crimes.
Excerpt from Lynn M. Paltrow's Letter (full letter available on request):
The administration apparently seeks to justify this rule change based in part
on the suggestion that there are medical procedures that apply exclusively to
the fetus. . Surgery on the fetus [however] occurs only through the woman's
body and can occur only with her consent. Surgery on the fetus moreover,
presents significant risks to the pregnant woman's life and health. As the
"United States government's principal agency for protecting the health of all
Americans," failure to acknowledge the impact such surgery can have on
pregnant women suggests a lack of basic medical knowledge and procedure that
is profoundly disturbing. The portrayal of these procedures as independent
of the pregnant woman's body and life suggests an extreme disregard for
pregnant women and mothers.
To our knowledge, no research supports the claim that so called "fetal
surgery" can "ultimately lower post-partum medical care costs." While
long-term research in this field may someday produce such beneficial results,
the suggestion that these cost-savings currently exist is without support.
Similarly, the claim that: "Once detected, such conditions can often be
surgically or medically treated in utero," with beneficial consequences is
without basis in science at this time.
Despite the fact that fetal surgery is at this stage largely experimental,
the Notice of Proposed Rule Making explicitly states that the "Secretary
would like to permit the States the flexibility to pay for the medical
expenses related to unborn children" suggesting a departure from longstanding
state and federal policy regarding experimental treatments. As documented in
the Morgan & Casper letter, the procedures described in the rule continue to
be highly experimental and investigational. Long standing state and federal
policy has been to deny coverage for experimental treatments. . . Similarly,
private insurers, some of whom provide care under S-CHIP programs generally
do not cover experimental treatments.
The proposed rule thus seems either to signal a radical shift in policy
regarding experimental treatments, or to be deliberately misleading,
suggesting that the door is opening to experimental treatments, when in fact
it is not. NAPW however would certainly be interested in additional
information on this point, since there are many patients suffering from
cancer and other diseases who might benefit from an overall change in policy
regarding experimental treatments.
Finally, some physicians and ethicists argue that procedures described as
"fetal surgery" are so new and so lacking in proven benefits that they must
be considered research. See, e.g., Anne E. Drapkin Lyerly, MD et al, Toward
the Ethical Evaluation and Use of Maternal-Fetal Surgery, 98 ACOG 689 (2001).
The Notice of Proposed Rule Making thus appears to promote what is
essentially unreviewed and unapproved research on pregnant human subjects
presenting a direct conflict with the laws regarding Human Subjects of
Medical Research. See 45 C.F.R. §§ 46.101- 46.409, promulgated pursuant to
the Health Research Extension Act , 42 USC § 289.
1. http://www.hhs.gov/news/press/2002pres/profile.html (emphasis added).
2. See e.g. New York State's Child Health Plus Exclusions: "The following
services will not be covered: Experimental medical or surgical procedures."
http://www.health.state.ny.us/nysdoh/child/schip99a.wpd at 16 .
Lynn M. Paltrow
Executive Director
National Advocates for Pregnant Women
45 West 10th Street #3F
New York, New York 10011
212-475-4218
212-254-9679 (fax)
LMPNYC@aol.com
http://www.advocatesforpregnantwomen.org/
|